CClinicalTrials.gg
TerminatedNCT00477347Drone-THUpdated Sep 23, 2016

Closed-loop Anesthesia, Using Bispectral Index as the Control Variable, During Liver Transplantation

A Phase 4 interventional study of Closed loop administration and Manual administration in Liver Transplantation, sponsored by Hopital Foch. Terminated at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-09-23.

Sponsored by Hopital Foch · Phase 4, Interventional, and Treatment

Why this study was terminated
lack of recrutment
Phase
Phase 4
Study type
Interventional
Enrollment
5
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

To compare closed-loop anesthesia to manual administration of propofol and remifentanil during liver transplantation

Read the detailed description

The Bispectral Index (BIS) is an electroencephalogram-derived measure of anesthetic depth. We hypothesized that BIS can also indicate the adequacy of analgesia. Therefore we built a combined closed-loop anesthesia system using BIS as control variable and two proportional-differential control algorithms, a propofol and a remifentanil target-controlled infusion system. The effectiveness of such a closed-loop anesthesia system has been demonstrated in a prospective, randomized study.

Elimination of anesthetic agents, propofol in particular, is strongly reduced during liver transplantation. Closed-loop anesthesia could provide adequacy for requirements in respect to the various phases of transplantation. Two groups of patients are compared: one in which propofol and remifentanil are administered by the anesthesiologist, using target-controlled infusion systems, and one in which propofol and remifentanil are administered automatically by the combined closed-loop anesthesia system. In both groups the goal is to maintain BIS between 40 and 60, the range recommended by the manufacturer during anesthesia. We expect the combined closed-loop anesthesia system group to do better: i.e. diminished consumption of propofol (primary outcome measure).

02

Conditions studied

  • Liver Transplantation

Keywords

  • Liver Transplantation
  • Anesthesia, general
  • Closed-loop
03

In context

Lead sponsor

Hopital Foch is the lead sponsor of 208 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • liver transplantation

Exclusion criteria

Exclusion Criteria:

  • pregnant women
  • allergy to propofol or remifentanil,
  • neurological or muscular disorder,
  • liver encephalopathy,
  • patients taking psychotropic agents
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
5 participants (actual)

Study arms

  • Active comparator
    1

    Manual administration

    Device: Manual administration

  • Experimental
    2

    Closed-loop administration

    Device: Closed loop administration

Interventions

  • DeviceClosed loop administration

    intraoperative closed loop administration of propofol and remifentanil

    Also known as: closed-loop

  • DeviceManual administration

    intraoperative manual administration of propofol and remifentanil

    Also known as: target controlled anesthesia

06

What researchers measure

Primary outcomes

  1. consumption of propofol during anesthesia maintenance

    Time frame: during anesthesia maintenance

Secondary outcomes

  1. - consumption of remifentanil - target modifications - hemodynamic events - volume loading and transfusion - extubation time, explicit memorization - time passed at BIS between 40 and 60 - MDAPE, wobble - global score - dysfunction of each system.

    Time frame: during anesthesia maintenance

07

Study locations

2 sites
  • Dept of Anesthesia and Intensive Care, Hôpital Beaujon
    Clichy, 92110, France
  • Dept of Anesthesia and Intensive Care, Hôpital H. Mondor
    Créteil, 94000, France
08

References and documents

Publications

  • Liu N, Chazot T, Genty A, Landais A, Restoux A, McGee K, Laloe PA, Trillat B, Barvais L, Fischler M. Titration of propofol for anesthetic induction and maintenance guided by the bispectral index: closed-loop versus manual control: a prospective, randomized, multicenter study. Anesthesiology. 2006 Apr;104(4):686-95. doi: 10.1097/00000542-200604000-00012. PubMed 16571963 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 23, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00477347
Lead sponsor
Hopital Foch
Responsible party
Sponsor
First posted
May 23, 2007
Start date
May 2007
Primary completion
Sep 2009
Completion
Sep 2009
Last update
Sep 23, 2016

Study contacts

Marc Fischler, MD
principal investigator

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion